Header cover image

Australian (ASX) Pharma Industry Analysis

UpdatedFeb 20, 2024
DataAggregated Company Financials
Companies32
  • 7D-4.4%
  • 3M30.7%
  • 1Y59.7%
  • YTD-6.5%

Over the last 7 days, the Pharma industry has dropped 4.4%, driven by Neuren Pharmaceuticals declining 11%. On the other hand PharmAust is actually up 40%. Over the past 12 months, the industry was up 60%. Looking forward, earnings are forecast to grow by 29% annually.

Industry Valuation and Performance

Has the Australian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 20 Feb 2024AU$5.4bAU$892.3m-AU$534,729,129.0020.6x-10.2x6.1x
Thu, 18 Jan 2024AU$5.6bAU$896.3m-AU$589,604,392.0021x-9.5x6.3x
Sat, 16 Dec 2023AU$4.6bAU$896.3m-AU$589,604,392.0017.8x-7.8x5.1x
Mon, 13 Nov 2023AU$4.0bAU$893.0m-AU$595,020,018.0018.1x-6.7x4.5x
Wed, 11 Oct 2023AU$3.5bAU$900.3m-AU$587,952,018.0019.3x-5.9x3.9x
Fri, 08 Sep 2023AU$3.6bAU$900.3m-AU$587,952,018.0019.5x-6.2x4x
Sun, 06 Aug 2023AU$4.1bAU$999.0m-AU$624,794,303.0021.1x-6.5x4.1x
Tue, 04 Jul 2023AU$4.0bAU$999.0m-AU$624,794,303.0024.3x-6.3x4x
Thu, 01 Jun 2023AU$4.1bAU$993.2m-AU$640,306,659.0018.8x-6.3x4.1x
Sat, 29 Apr 2023AU$4.3bAU$993.2m-AU$641,969,868.0020.5x-6.7x4.3x
Mon, 27 Mar 2023AU$4.0bAU$995.9m-AU$648,651,745.0018.2x-6.2x4.1x
Wed, 22 Feb 2023AU$3.6bAU$981.5m-AU$594,318,566.0016.6x-6x3.6x
Fri, 20 Jan 2023AU$3.7bAU$948.3m-AU$544,428,006.0013x-6.9x3.9x
Sun, 18 Dec 2022AU$3.9bAU$948.3m-AU$544,428,006.0013.3x-7.1x4.1x
Tue, 15 Nov 2022AU$4.3bAU$948.3m-AU$544,428,005.0013.2x-7.9x4.5x
Thu, 13 Oct 2022AU$4.2bAU$882.1m-AU$556,645,005.0012.2x-7.5x4.7x
Sat, 10 Sep 2022AU$4.2bAU$943.4m-AU$537,548,829.0012.7x-7.8x4.4x
Mon, 08 Aug 2022AU$3.9bAU$819.9m-AU$339,669,589.0015.6x-11.6x4.8x
Wed, 06 Jul 2022AU$3.4bAU$818.2m-AU$353,932,589.0013.2x-9.5x4.1x
Fri, 03 Jun 2022AU$3.9bAU$818.2m-AU$353,932,589.0014.8x-11.1x4.8x
Sun, 01 May 2022AU$4.1bAU$800.9m-AU$348,637,558.0015.7x-11.7x5.1x
Tue, 29 Mar 2022AU$4.2bAU$799.2m-AU$341,805,125.0018.1x-12.4x5.3x
Thu, 24 Feb 2022AU$4.4bAU$743.6m-AU$460,156,833.0019.9x-9.6x5.9x
Sat, 22 Jan 2022AU$4.8bAU$758.4m-AU$450,516,414.0020.6x-10.6x6.3x
Mon, 20 Dec 2021AU$4.8bAU$758.4m-AU$450,516,414.0023.7x-10.5x6.3x
Wed, 17 Nov 2021AU$4.9bAU$758.4m-AU$447,307,205.0024.1x-11x6.5x
Fri, 15 Oct 2021AU$4.7bAU$753.7m-AU$446,965,453.0023.5x-10.6x6.3x
Sun, 12 Sep 2021AU$4.8bAU$753.9m-AU$445,060,581.0021.9x-10.7x6.3x
Tue, 10 Aug 2021AU$4.1bAU$752.8m-AU$442,004,016.0021.3x-9.3x5.4x
Mon, 03 May 2021AU$4.8bAU$758.7m-AU$449,177,839.0012.3x-10.6x6.3x
Price to Earnings Ratio

-10x


Total Market Cap: AU$4.8bTotal Earnings: -AU$478,696,362.00Total Revenue: AU$759.6mTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Pharma Industry Price to Earnings3Y Average -8.9x202220232024
Current Industry PE
  • Investors are optimistic on the Australian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 5.1x is lower than the industry's current PS ratio of 6.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 5.5% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Australian Healthcare industry?

AU Market0.64%
Healthcare-3.02%
Pharma-4.41%
Pharma-4.41%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PAA PharmAustAU$0.2440.0%
+AU$27.1m
214.1%PS24.8x
ALA Arovella TherapeuticsAU$0.185.9%
+AU$9.2m
429.4%PS113.6x
MVP Medical Developments InternationalAU$0.9810.1%
+AU$7.8m
-27.0%PS2.6x
VIT Vitura HealthAU$0.254.2%
+AU$5.8m
-52.8%PE10.4x
PBP ProbiotecAU$2.872.5%
+AU$5.7m
22.6%PE21.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IXC

AU$0.10

Invex Therapeutics

7D

22.0%

1Y

-79.2%

MYX

AU$5.27

Mayne Pharma Group

7D

-3.8%

1Y

72.2%

PER

AU$0.069

Percheron Therapeutics

7D

-9.2%

1Y

-31.0%

CU6

AU$2.62

Clarity Pharmaceuticals

7D

-0.8%

1Y

219.5%

PAA

AU$0.24

PharmAust

7D

40.0%

1Y

214.1%

VLS

AU$1.95

Vita Life Sciences

7D

2.4%

1Y

29.7%

RCE

AU$0.48

Recce Pharmaceuticals

7D

-5.0%

1Y

-17.2%

LGP

AU$0.13

Little Green Pharma

7D

-7.1%

1Y

-31.6%

PBP

AU$2.87

Probiotec

7D

2.5%

1Y

22.6%

CAN

AU$0.071

Cann Group

7D

-9.0%

1Y

-60.6%

ALA

AU$0.18

Arovella Therapeutics

7D

5.9%

1Y

429.4%

AVE

AU$0.0035

Avecho Biotechnology

7D

16.7%

1Y

-61.1%